Gender-Specific Risks for Incident Cancer in Patients with Different Heart Failure Phenotypes
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15097 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Qin-Fen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Care Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Heart Failure, Neoplasms, Stroke Volume. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wenzhou Science Technology Bureau Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
There is conflicting evidence regarding whether heart failure (HF) increases the risk of developing cancer.
Objective
This study aimed to assess the association between HF and incident cancer, considering gender differences and HF phenotypes.
Methods
This retrospective study was conducted on data of adult individuals, free of cancer at baseline, from the First Affiliated Hospital of Wenzhou Medical University between January 2009 and February 2023. The patients with HF were categorized as HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF). The primary outcome was incident cancer, including obesity-related, tobacco-related, lung, colorectal and breast cancers.
Results
Of 33 033 individuals enrolled, 16 722 were diagnosed with HF, including 10 086 (60.3%) with HFpEF and 6636 (39.7%) with HFrEF. During a median follow-up period of 4.6 years (inter-quartile range: 2.6–7.3), incident cancer was diagnosed in 10.5% (1707 patients) of the non-HF group and 15.1% (2533 individuals) of the HF group. After adjusting for potential confounding factors, patients with HF had a 58% increased risk of cancer than those without HF [adjusted hazard ratio (HR) 1.58, 95% confidence interval (CI) 1.48–1.69, P < 0.001]. This risk was consistent across genders (female: adjusted HR 1.95, 95% CI 1.74–2.18, P < 0.001; male: adjusted HR 1.41, 95% CI 1.30–1.54, P < 0.001) and HF phenotypes (HFpEF: adjusted HR 1.69, 95% CI 1.57–1.81, P < 0.001; HFrEF: adjusted HR 1.32, 95% CI 1.20–1.46, P < 0.001).
Conclusions
Both HFpEF and HFrEF are associated with an increased risk of incident cancer. This correlation maintains its validity across genders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Care Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou Medical University, Wenzhou, China.
- First Department of Cardiology, University Hospital of Ioannina Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
- Department of Cardiovascular Medicine, the Heart Center, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Wenzhou Medical University Renji College, Wenzhou, China.
- Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Xiao-Dong Zhou
Förderung
- Wenzhou Science Technology Bureau Foundation
Zitieren
APA
Chen, Q. F., Katsouras, C. S., Liu, C., Shi, J., Luan, X., Ni, C., Yao, H., Lu, Y., Lin, W. H., & Zhou, X. D. (2025). Gender-Specific Risks for Incident Cancer in Patients with Different Heart Failure Phenotypes. ESC Heart Failure. https://doi.org/10.1002/ehf2.15097
Vancouver
Chen QF, Katsouras CS, Liu C, Shi J, Luan X, Ni C, et al. Gender-Specific Risks for Incident Cancer in Patients with Different Heart Failure Phenotypes. ESC Heart Failure. 2025. doi:10.1002/ehf2.15097
BibTeX
@article{Chen2025,
author = {Chen, Qin-Fen and Katsouras, Christos S and Liu, Chenyang and Shi, Jingjing and Luan, Xiaoqian and Ni, Chao and Yao, Hongxia and Lu, Yingdan and Lin, Wei-Hong and Zhou, Xiao-Dong},
title = {Gender-Specific Risks for Incident Cancer in Patients with Different Heart Failure Phenotypes},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15097}
}
EUVIMED